LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 37

Search options

  1. Article ; Online: Neurological Manifestations of SARS-CoV-2: A Narrative Review.

    Khan, Alizay R / Farooqui, Muhammad O / Jatoi, Nadia N / Jawaid, Samreen / Mahdi, Danial / Khosa, Faisal

    The neurologist

    2020  Volume 26, Issue 1, Page(s) 15–19

    Abstract: ... respiratory syndrome-coronavirus-2 to the host angiotensin-converting enzyme-2 receptors. Striking radiologic ... respiratory syndrome-coronavirus-2 may potentially have lethal implications on the nervous system, it is ... important that neurologists are better informed about the spectrum of clinical manifestations, radiologic ...

    Abstract Background: Coronavirus disease 2019 (COVID-19) pandemic started as an outbreak in China and soon crossed borders to affect the populations in all countries of the world. During the initial course of the disease, COVID-19 was perceived as a pneumonia-like illness. However, recent findings of COVID-19 patients suggest that the virus has the potential to disseminate to different tissues and organs, and cause significant complications.
    Summary: Neurological symptoms are of great significance as these usually present in and complicate critical cases. Many case reports and case series have documented the findings of neurological complications in COVID-19 patients. From the existing data, the most frequent symptoms in these patients were broadly classified into the central nervous system (CNS), peripheral nervous system, and skeletal muscular symptoms. CNS symptoms include meningitis, encephalitis, cerebrovascular complications, peripheral nervous system symptoms include anosmia, ageusia, and skeletal muscular symptoms include myalgias. It is postulated that the cause may be direct CNS injury through blood and neuronal pathways or indirectly because of an immune-mediated response, hypoxia caused by decreased oxygen saturation, or by the binding of subacute respiratory syndrome-coronavirus-2 to the host angiotensin-converting enzyme-2 receptors. Striking radiologic findings in COVID-19 patients with neurological symptoms have also emerged.
    Conclusions: As subacute respiratory syndrome-coronavirus-2 may potentially have lethal implications on the nervous system, it is important that neurologists are better informed about the spectrum of clinical manifestations, radiologic findings, and likely mechanisms of injury. Understanding the symptoms and radiologic imaging allows clinicians to consider brain imaging in any patient with suspected COVID-19 and neurological symptoms.
    MeSH term(s) COVID-19/complications ; Central Nervous System Diseases/diagnostic imaging ; Central Nervous System Diseases/etiology ; Central Nervous System Diseases/physiopathology ; Humans ; Musculoskeletal Diseases/diagnostic imaging ; Musculoskeletal Diseases/etiology ; Musculoskeletal Diseases/physiopathology ; Peripheral Nervous System Diseases/diagnostic imaging ; Peripheral Nervous System Diseases/etiology ; Peripheral Nervous System Diseases/physiopathology
    Language English
    Publishing date 2020-12-30
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1361380-7
    ISSN 2331-2637 ; 1074-7931
    ISSN (online) 2331-2637
    ISSN 1074-7931
    DOI 10.1097/NRL.0000000000000307
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.

    Maury, A / Lyoubi, A / Peiffer-Smadja, N / de Broucker, T / Meppiel, E

    Revue neurologique

    2020  Volume 177, Issue 1-2, Page(s) 51–64

    Abstract: ... range of neurological manifestations and diseases associated with SARS-CoV-2 is consistent with multiple ... with SARS-CoV-2 infection and raised the question of the neuropathogenicity of coronaviruses. The aim ... with few cases of inflammatory injuries. Only one case suggested SARS-CoV-2 infiltration in endothelial and ...

    Abstract Introduction: The past two decades have been marked by three epidemics linked to emerging coronaviruses. The COVID-19 pandemic highlighted the existence of neurological manifestations associated with SARS-CoV-2 infection and raised the question of the neuropathogenicity of coronaviruses. The aim of this review was to summarize the current data about neurological manifestations and diseases linked to human coronaviruses.
    Material and methods: Articles have been identified by searches of PubMed and Google scholar up to September 25, 2020, using a combination of coronavirus and neurology search terms and adding relevant references in the articles.
    Results: We found five cohorts providing prevalence data of neurological symptoms among a total of 2533 hospitalized COVID-19 patients, and articles focusing on COVID-19 patients with neurological manifestations including a total of 580 patients. Neurological symptoms involved up to 73% of COVID-19 hospitalized patients, and were mostly headache, myalgias and impaired consciousness. Central nervous system (CNS) manifestations reported in COVID-19 were mostly non-specific encephalopathies that represented between 13% and 40% of all neurological manifestations; post-infectious syndromes including acute demyelinating encephalomyelitis (ADEM, n=13), acute necrotizing encephalopathy (ANE, n=4), Bickerstaff's encephalitis (n=5), generalized myoclonus (n=3) and acute transverse myelitis (n=7); other encephalitis including limbic encephalitis (n=9) and miscellaneous encephalitis with variable radiologic findings (n=26); acute cerebrovascular diseases including ischemic strokes (between 1.3% and 4.7% of COVID-19 patients), hemorrhagic strokes (n=17), cerebral venous thrombosis (n=8) and posterior reversible encephalopathy (n=5). Peripheral nervous system (PNS) manifestations reported in COVID-19 were the following: Guillain-Barré syndrome (n=31) and variants including Miller Fisher syndrome (n=3), polyneuritis cranialis (n=2) and facial diplegia (n=2); isolated oculomotor neuropathy (n=6); critical illness myopathy (n=6). Neuropathological studies in COVID-19 patients demonstrated different patterns of CNS damage, mostly ischemic and hemorrhagic changes with few cases of inflammatory injuries. Only one case suggested SARS-CoV-2 infiltration in endothelial and neural cells. We found 10 case reports or case series describing 22 patients with neurological manifestations associated with other human coronaviruses. Among them we found four MERS patients with ADEM or Bickerstaff's encephalitis, two SARS patients with encephalitis who had a positive SARS-CoV PCR in cerebrospinal fluid, five patients with ischemic strokes associated with SARS, eight MERS patients with critical illness neuromyopathy and one MERS patient with Guillain-Barré Syndrome. An autopsy study on SARS-CoV patients demonstrated the presence of the virus in the brain of eight patients.
    Conclusion: The wide range of neurological manifestations and diseases associated with SARS-CoV-2 is consistent with multiple pathogenic pathways including post-infectious mechanisms, septic-associated encephalopathies, coagulopathy or endothelitis. There was no definite evidence to support direct neuropathogenicity of SARS-CoV-2.
    MeSH term(s) Brain Diseases/epidemiology ; Brain Diseases/etiology ; COVID-19/complications ; Coronavirus Infections/complications ; Coronavirus OC43, Human ; Female ; Guillain-Barre Syndrome/epidemiology ; Guillain-Barre Syndrome/etiology ; Humans ; Male ; Middle East Respiratory Syndrome Coronavirus ; Myelitis/epidemiology ; Myelitis/etiology ; Nervous System Diseases/epidemiology ; Nervous System Diseases/etiology ; SARS-CoV-2 ; Severe Acute Respiratory Syndrome/complications ; Stroke/epidemiology ; Stroke/etiology
    Language English
    Publishing date 2020-12-16
    Publishing country France
    Document type Journal Article ; Review
    ZDB-ID 4593-7
    ISSN 2213-0004 ; 0035-3787
    ISSN (online) 2213-0004
    ISSN 0035-3787
    DOI 10.1016/j.neurol.2020.10.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Long COVID: neurological manifestations - an updated narrative review.

    Leonel, José Wagner / Ciurleo, Gabriella Cunha Vieira / Formiga, Alissa Moura / Vasconcelos, Thais de Maria Frota / de Andrade, Marcello Holanda / Feitosa, Werbety Lucas Queiroz / Sobreira-Neto, Antônio Alves / Portugal, Chiara Gübel / Morais, Lorenzo Marinho / Marinho, Samuel Cavalcante / Gomes, Emanuel de Assis Bertulino Martins / Feitosa, Esther de Alencar Araripe Falcão / Sobreira, Emmanuelle Silva Tavares / Oriá, Reinaldo Barreto / Sobreira-Neto, Manoel Alves / Braga-Neto, Pedro

    Dementia & neuropsychologia

    2024  Volume 18, Page(s) e20230076

    Abstract: Infection with the SARS-CoV-2 virus can lead to neurological symptoms in the acute phase and ... hovering around 3.7 trillion US dollars. In this review, we will sequentially describe the current ... manifestations, headache and others. This condition is more commonly described in young adults and women ...

    Abstract Infection with the SARS-CoV-2 virus can lead to neurological symptoms in the acute phase and in the Long COVID phase. These symptoms usually involve cognition, sleep, smell disorders, psychiatric manifestations, headache and others. This condition is more commonly described in young adults and women. This symptomatology can follow severe or mild cases of the disease. The importance of this issue resides in the high prevalence of neurological symptoms in the Long COVID phase, which entails significant morbidity in this population. In addition, such a condition is associated with high health care costs, with some estimates hovering around 3.7 trillion US dollars. In this review, we will sequentially describe the current knowledge about the most prevalent neurological symptoms in Long COVID, as well as their pathophysiology and possible biomarkers.
    Language English
    Publishing date 2024-02-09
    Publishing country Brazil
    Document type Journal Article ; Review
    ISSN 1980-5764
    ISSN 1980-5764
    DOI 10.1590/1980-5764-DN-2023-0076
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Neurological manifestations in coronavirus disease 2019.

    Corona, Teresita / Rodríguez-Violante, Mayela / Delgado-García, Guillermo

    Gaceta medica de Mexico

    2020  Volume 156, Issue 4, Page(s) 317–320

    Abstract: ... practice. Since maybe not all COVID-19 neurological manifestations are due to SARS-CoV-2 direct effects ... coronavirus 2 (SARS-CoV-2), is currently hitting the world in the form of a pandemic. Given that some reports ... suggest that this infection can also occur with neurologic manifestations, this narrative review addresses ...

    Title translation Manifestaciones neurológicas en la enfermedad del coronavirus 2019.
    Abstract Coronavirus disease 2019 (COVID-19), an infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is currently hitting the world in the form of a pandemic. Given that some reports suggest that this infection can also occur with neurologic manifestations, this narrative review addresses the basic and clinical aspects concerning the nervous system involvement associated with this disease. More than one third of patients hospitalized for COVID-19 can present with both central and peripheral neurological manifestations. The former include dizziness and headache, while the latter include taste and smell disturbances. Other reported neurological manifestations are cerebrovascular disease and epileptic seizures. According to published reports, neurological disorders are not uncommon in COVID-19 and can sometimes represent the first manifestation of the disease; therefore, neurologists should consider this diagnostic possibility in their daily practice. Since maybe not all COVID-19 neurological manifestations are due to SARS-CoV-2 direct effects, it is important to monitor the rest of the clinical parameters such as, for example, oxygen saturation. Similarly, follow-up of patients is advisable, since whether neurological complications may develop lately is thus far unknown.
    MeSH term(s) Betacoronavirus/isolation & purification ; COVID-19 ; COVID-19 Testing ; Clinical Laboratory Techniques ; Coronavirus Infections/complications ; Coronavirus Infections/diagnosis ; Coronavirus Infections/epidemiology ; Dizziness/virology ; Headache/virology ; Humans ; Nervous System Diseases/diagnosis ; Nervous System Diseases/epidemiology ; Nervous System Diseases/virology ; Olfaction Disorders/virology ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/epidemiology ; SARS-CoV-2 ; Taste Disorders/virology
    Keywords covid19
    Language English
    Publishing date 2020-08-24
    Publishing country Mexico
    Document type Journal Article ; Review
    ZDB-ID 425456-9
    ISSN 0016-3813
    ISSN 0016-3813
    DOI 10.24875/GMM.20000195
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Neurological manifestations in COVID-19

    Rahman, Asma / Niloofa, Roshan / De Zoysa, Ishan M / Cooray, Akila D / Kariyawasam, Jayani / Seneviratne, Suranjith L

    SAGE Open Medicine

    A narrative review

    2020  Volume 8, Page(s) 205031212095792

    Abstract: ... by SARS-CoV-2 are a possibility. We have outlined the common neurological manifestations in COVID-19 ... the nervous system. Given the high similarity between SARS-CoV-1 and SARS-CoV-2, effects on the nervous system ... smell and taste impairment. In previous studies, SARS-CoV-1 and MERS-CoV were found to affect ...

    Abstract COVID-19, a respiratory viral infection, has affected more than 10 million individuals worldwide. Common symptoms include fever, dry cough, fatigue and shortness of breath. Some patients show neurological manifestations such as headache, dizziness, cerebrovascular disease, peripheral nerve and muscle symptoms and smell and taste impairment. In previous studies, SARS-CoV-1 and MERS-CoV were found to affect the nervous system. Given the high similarity between SARS-CoV-1 and SARS-CoV-2, effects on the nervous system by SARS-CoV-2 are a possibility. We have outlined the common neurological manifestations in COVID-19 (information are up-to-date as of June 2020) and discussed the possible pathogenetic mechanisms and management options.
    Keywords General Medicine ; covid19
    Language English
    Publisher SAGE Publications
    Publishing country us
    Document type Article ; Online
    ZDB-ID 2735399-0
    ISSN 2050-3121
    ISSN 2050-3121
    DOI 10.1177/2050312120957925
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: Neurological manifestations in COVID-19

    Asma Rahman / Roshan Niloofa / Ishan M De Zoysa / Akila D Cooray / Jayani Kariyawasam / Suranjith L Seneviratne

    SAGE Open Medicine, Vol

    A narrative review

    2020  Volume 8

    Abstract: ... by SARS-CoV-2 are a possibility. We have outlined the common neurological manifestations in COVID-19 ... the nervous system. Given the high similarity between SARS-CoV-1 and SARS-CoV-2, effects on the nervous system ... smell and taste impairment. In previous studies, SARS-CoV-1 and MERS-CoV were found to affect ...

    Abstract COVID-19, a respiratory viral infection, has affected more than 10 million individuals worldwide. Common symptoms include fever, dry cough, fatigue and shortness of breath. Some patients show neurological manifestations such as headache, dizziness, cerebrovascular disease, peripheral nerve and muscle symptoms and smell and taste impairment. In previous studies, SARS-CoV-1 and MERS-CoV were found to affect the nervous system. Given the high similarity between SARS-CoV-1 and SARS-CoV-2, effects on the nervous system by SARS-CoV-2 are a possibility. We have outlined the common neurological manifestations in COVID-19 (information are up-to-date as of June 2020) and discussed the possible pathogenetic mechanisms and management options.
    Keywords Medicine (General) ; R5-920 ; covid19
    Language English
    Publishing date 2020-09-01T00:00:00Z
    Publisher SAGE Publishing
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article: Neurological manifestations in COVID-19: A narrative review.

    Rahman, Asma / Niloofa, Roshan / De Zoysa, Ishan M / Cooray, Akila D / Kariyawasam, Jayani / Seneviratne, Suranjith L

    SAGE open medicine

    2020  Volume 8, Page(s) 2050312120957925

    Abstract: ... by SARS-CoV-2 are a possibility. We have outlined the common neurological manifestations in COVID-19 ... the nervous system. Given the high similarity between SARS-CoV-1 and SARS-CoV-2, effects on the nervous system ... smell and taste impairment. In previous studies, SARS-CoV-1 and MERS-CoV were found to affect ...

    Abstract COVID-19, a respiratory viral infection, has affected more than 10 million individuals worldwide. Common symptoms include fever, dry cough, fatigue and shortness of breath. Some patients show neurological manifestations such as headache, dizziness, cerebrovascular disease, peripheral nerve and muscle symptoms and smell and taste impairment. In previous studies, SARS-CoV-1 and MERS-CoV were found to affect the nervous system. Given the high similarity between SARS-CoV-1 and SARS-CoV-2, effects on the nervous system by SARS-CoV-2 are a possibility. We have outlined the common neurological manifestations in COVID-19 (information are up-to-date as of June 2020) and discussed the possible pathogenetic mechanisms and management options.
    Keywords covid19
    Language English
    Publishing date 2020-09-10
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2735399-0
    ISSN 2050-3121
    ISSN 2050-3121
    DOI 10.1177/2050312120957925
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Neurological Manifestations of SARS-CoV2 Infection: A Narrative Review.

    Pavel, Bogdan / Moroti, Ruxandra / Spataru, Ana / Popescu, Mihaela Roxana / Panaitescu, Anca Maria / Zagrean, Ana-Maria

    Brain sciences

    2022  Volume 12, Issue 11

    Abstract: ... some of the manifestations of SARS-CoV-2-induced neurological impairment. Recent publications have revealed important aspects ... 2019 and September 2022. We discussed in narrative form the neurological impairment associated ... with COVID-19, including clinical signs and symptoms, imaging abnormalities, and the pathophysiology of SARS ...

    Abstract The COVID-19 virus frequently causes neurological complications. These have been described in various forms in adults and children. Headache, seizures, coma, and encephalitis are some of the manifestations of SARS-CoV-2-induced neurological impairment. Recent publications have revealed important aspects of viral pathophysiology and its involvement in nervous-system impairment in humans. We evaluated the latest literature describing the relationship between COVID-19 infection and the central nervous system. We searched three databases for observational and interventional studies in adults published between December 2019 and September 2022. We discussed in narrative form the neurological impairment associated with COVID-19, including clinical signs and symptoms, imaging abnormalities, and the pathophysiology of SARS-CoV2-induced neurological damage.
    Language English
    Publishing date 2022-11-12
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2651993-8
    ISSN 2076-3425
    ISSN 2076-3425
    DOI 10.3390/brainsci12111531
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Neurological manifestations of long-COVID syndrome: a narrative review.

    Stefanou, Maria-Ioanna / Palaiodimou, Lina / Bakola, Eleni / Smyrnis, Nikolaos / Papadopoulou, Marianna / Paraskevas, George P / Rizos, Emmanouil / Boutati, Eleni / Grigoriadis, Nikolaos / Krogias, Christos / Giannopoulos, Sotirios / Tsiodras, Sotirios / Gaga, Mina / Tsivgoulis, Georgios

    Therapeutic advances in chronic disease

    2022  Volume 13, Page(s) 20406223221076890

    Abstract: ... with antecedent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, while an approximately ... to prevail in propagating neurological 'long-COVID' sequelae. In this narrative review, we sought to present ... reported data. The most frequent neurological manifestations of 'long-COVID' encompass fatigue; 'brain fog' ...

    Abstract Accumulating evidence points toward a very high prevalence of prolonged neurological symptoms among coronavirus disease 2019 (COVID-19) survivors. To date, there are no solidified criteria for 'long-COVID' diagnosis. Nevertheless, 'long-COVID' is conceptualized as a multi-organ disorder with a wide spectrum of clinical manifestations that may be indicative of underlying pulmonary, cardiovascular, endocrine, hematologic, renal, gastrointestinal, dermatologic, immunological, psychiatric, or neurological disease. Involvement of the central or peripheral nervous system is noted in more than one-third of patients with antecedent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, while an approximately threefold higher incidence of neurological symptoms is recorded in observational studies including patient-reported data. The most frequent neurological manifestations of 'long-COVID' encompass fatigue; 'brain fog'; headache; cognitive impairment; sleep, mood, smell, or taste disorders; myalgias; sensorimotor deficits; and dysautonomia. Although very limited evidence exists to date on the pathophysiological mechanisms implicated in the manifestation of 'long-COVID', neuroinflammatory and oxidative stress processes are thought to prevail in propagating neurological 'long-COVID' sequelae. In this narrative review, we sought to present a comprehensive overview of our current understanding of clinical features, risk factors, and pathophysiological processes of neurological 'long-COVID' sequelae. Moreover, we propose diagnostic and therapeutic algorithms that may aid in the prompt recognition and management of underlying causes of neurological symptoms that persist beyond the resolution of acute COVID-19. Furthermore, as causal treatments for 'long-COVID' are currently unavailable, we propose therapeutic approaches for symptom-oriented management of neurological 'long-COVID' symptoms. In addition, we emphasize that collaborative research initiatives are urgently needed to expedite the development of preventive and therapeutic strategies for neurological 'long-COVID' sequelae.
    Language English
    Publishing date 2022-02-17
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2554816-5
    ISSN 2040-6231 ; 2040-6223
    ISSN (online) 2040-6231
    ISSN 2040-6223
    DOI 10.1177/20406223221076890
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: A Narrative Review of Neurological Complications of SARS-CoV-2 Vaccination

    Bithal, Parmod K. / Rajagopalan, Vanitha

    Journal of Neuroanaesthesiology and Critical Care

    2024  

    Abstract: ... authorization. The majority of the neurological manifestations of SARS-CoV-2 vaccination are usually mild, brief ... neurological manifestations related to SARS-CoV-2 vaccines published in the literature from 2021 to mid-2023. ... on the spectrum of neurological side effects of SARS-CoV-2 vaccines, which were accorded emergency use ...

    Abstract Adverse reactions to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine depict a tropism for neural structures. This narrative review was aimed to discuss published data on the spectrum of neurological side effects of SARS-CoV-2 vaccines, which were accorded emergency use authorization. The majority of the neurological manifestations of SARS-CoV-2 vaccination are usually mild, brief, self-limiting, and easily manageable. Rarely, these side effects can be of serious nature and require hospitalization. High vigilance helps in early identification and treatment of these complications leading to good outcomes. The reported incidence of neurological complications in vaccinated population is a miniscule, and the overall benefits of the vaccine outweigh the risks of side effects. However, it is crucial to conduct larger collaborative multicenter studies to prove or reject the causal association between the SARS-CoV-2 vaccines and the postvaccination neurological side effects. Herein, we have tried to summarize the various neurological manifestations related to SARS-CoV-2 vaccines published in the literature from 2021 to mid-2023.
    Keywords COVID-19 ; SARS-CoV-2 vaccine ; Postvaccination neurological complications
    Language English
    Publishing date 2024-05-02
    Publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 2937287-2
    ISSN 2348-926X ; 2348-0548
    ISSN (online) 2348-926X
    ISSN 2348-0548
    DOI 10.1055/s-0044-1782508
    Database Thieme publisher's database

    More links

    Kategorien

To top